DIRS.INFO The most relevant business & tech news

☆ A tech investor got brutally roasted after he shared the detailed Notion database he uses to manage his marriage. He says the haters don't get that he's just being organized.
▼ + stars: | 2024-04-12 | by ( Kwan Wei Kevin Tan | ) www.businessinsider.com time to read: +4 min

Related story"I would say I'm definitely the one who drives the structure of the page and how we use Notion," Lang said. So I figured what I would do is, I would just make a parody of their responses," Lang told BI. On April 9, Lang posted a screenshot of what he said was an updated copy of his Notion template. Here’s the next iteration of my Notion template for couples. "They could be thinking, 'Oh, there's this couple who are controlled by this Notion page and it's how they live their life every moment.'

Persons: —, Ben Lang, Lang, There's, — Ben Lang, one's, “, Trung Phan, that's Organizations: Service, Business, BI

☆ Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
▼ + stars: | 2024-03-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +13 min

Now, the company is betting on cancer drugs to help it regain its footing after a rocky year marked by the rapid decline of its Covid business. That $43 billion Seagen acquisition doubled Pfizer's oncology drug pipeline to 60 different experimental programs. Some analysts noted that it might take a few years for some of Pfizer's cancer drugs in mid-stage development to show pivotal clinical trial data and become less risky. Revenue from the blockbuster breast cancer drug Ibrance and prostate cancer treatment Xtandi, which Pfizer shares with Astellas Pharma, has declined over the past year. They are among the most expensive prescription drugs in the U.S. Before the Seagen deal, 94% of Pfizer's cancer products were small-molecule drugs.

Persons: Wall, Seagen, Chris Boshoff, Boshoff, David Ryder, Trung Huynh, Joe Biden's, Chris Schott, Suneet Varma, RemeGe, Merck, Padcev, Guggenheim, Pfizer's, Pfizer hasn't, Dr, Mikael Dolsten, Irfan Khan Organizations: Nurphoto, Getty, Pfizer, Astellas Pharma, Guggenheim, Bloomberg, UBS, Medicare, Drug Administration, FDA, ADC, JPMorgan, Drugs, CNBC, CVS Pharmacy, Los Angeles Times Locations: Covid, Bothell , Washington, U.S, biologics, China, Eagle Rock , California

☆ The Endangered Languages of New York
▼ + stars: | 2024-02-22 | by ( Alex Carp | ) www.nytimes.com time to read: +19 min

Most people think of endangered languages as far-flung or exotic, the opposite of cosmopolitan. All told, there are more endangered languages in and around New York City than have ever existed anywhere else, says Perlin, who has spent 11 years trying to document them. She has published children’s books in Wakhi and other endangered languages of the Pamir mountains in Central Asia. By the start of the pandemic, the city had begun official outreach in nine Indigenous languages and recorded videos in several other endangered languages. We cross-referenced E.L.A.’s New York City language list with three independent databases that track the threat level of languages around the world: Ethnologue, which catalogs all known living languages in the world; UNESCO’s World Atlas of Languages, a survey of all the languages spoken in UNESCO member states; and the Endangered Languages Project, a site to which the public can contribute content, managed by the First Peoples’ Cultural Council and the Endangered Languages Catalogue (ELCat) project at the University of Hawaii at Manoa.

Persons: Bukhori, Zaza Bartangi, Alex Carp, Ross Perlin, Perlin, Zenaida Cantu, Ikhiil Mardakhayev, Ken Hale, Michael Krauss, Krauss, ” Eleanor Castillo Bullock, Eleanor Castillo Bullock, Gloria Angeles, Gloria Tadii, ’, Daniel Kaufman, Trung, Kaufman, ” Kaufman, Gola, Rasmina Gurung, Safiyatou, E.L.A, ”, “ Ahh, “, —, Ganja Perlin, Ibrahima Traore, Kamel Mrowa, Kante, Husniya Khujamyorova, Pamiri, ” Perlin, Seke, ” Gurung, ” Irwin Sanchez, ” Patricia Tarrant, Patricia Tarrant, Thelma Carrillo, Carrillo, Uttam Singha, Singha, Jean James, Jean, Gurung, doesn’t, Ibrahima Traore's, Coleman Donaldson Organizations: Lenape, Scottish, U.S, Arts Medicine Agriculture Education International, Rebeldía, Language Alliance, Perlin, Rockefeller Center, American Indian Community House, city’s Health Department, Manipuri, New York City, Endangered Language Alliance, of, UNESCO, First, Cultural, University of Hawaii Locations: Syrian, Pangasinan, Nauaran, Kurdish Moroccan, Zaza Bartangi Puerto, Taíno, New York City, New York, Nepal, Brooklyn, Bangladesh, India, Queens, Central Mexico, Mexico, Israel, Hope, Belize, Kukaa, Oaxaca, Manhattan, E.L.A, QUEENS, Pangasinan Kham, Woodside, Elmhurst, Jackson, Tshugsang, Kathmandu, Brooklyn , New York, America, Roosevelt, Gabon, Republic of Congo, Language, ”, Australian, — Culiacán, Mexico City , New York, Los Angeles, Ganja, Harlem, Bronx, Montclair , N.J, “, Bouaké, Lebanon, Midwood , Brooklyn, Wakhi, Central Asia, Pamir, Tibet, city’s, New, Latin America, United States, Jamaica Estates, Staten, Lummi, Manoa

☆ Marc Benioff is trying to use X to poach talent from OpenAI, and people are having a field day in the comments
▼ + stars: | 2023-11-21 | by ( Kai Xiang Teo | ) www.businessinsider.com time to read: +3 min

Salesforce CEO Marc Benioff is trying to get ahead of the race to poach OpenAI's talent. AdvertisementAfter the weekend of chaos at OpenAI, Salesforce CEO Marc Benioff is eyeing an opportunity for new talent. "Lol, like it was ever about compensation," wrote Boris Power, OpenAI's head of applied research, in response to Benioff. "Looking forward to joining Salesforce!" I was the janitor at OpenAI, total comp $1.2m base + $50m equityLook forward to joining Salesforce!

Persons: Marc Benioff, —, Salesforce's Einstein, Lol, Boris Power, ove, ould Organizations: Service, Salesforce's Locations: OpenAI, ife

☆ Here's what Wall Street is saying about obesity drug Wegovy following Novo Nordisk's key study
▼ + stars: | 2023-11-13 | by ( Alex Harring | ) www.cnbc.com time to read: +6 min

Wegovy contains semaglutide, the same active ingredient in Novo's type 2 diabetes drug Ozempic. A rising tide for Eli Lilly? Though the study was specifically about Wegovy, Wall Street sees a positive readthrough for similar medications from other providers, particularly Eli Lilly 's Zepbound. Similarly, UBS analyst Trung Huynh called the weekend data a "best-case" scenario for Eli Lilly. And the positive outcomes for both in the Wegovy study can be viewed as encouraging for how Zepbound should perform, the analyst added.

Persons: Morgan Stanley, Mark Purcell, Richard Vosser, Peter Verdult, Eli Lilly, Eli Lilly's, Lilly, Andrew Baum, Trung Huynh, That's, it's, Zepbound, Huynh, Citi's Baum, James Shin isn't, Michael Bloom, Christina Cheddar Berk, Angelica Peebles Organizations: Novo Nordisk, American Heart Association, cardiologists, JPMorgan, Citi, ., UBS, North American, Tandem Diabetes Care, Deutsche Bank

☆ UBS upgrades this biopharma giant with an underappreciated treatment pipeline
▼ + stars: | 2023-10-20 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

Investors may not be fully pricing in Merck 's strong treatment pipeline, according to UBS. Analyst Trung Huynh expects that "underappreciated pipeline readouts" will be the primary contributor to multiple expansion for the company. Huynh also noted that investors continue to underestimate the value of two key Merck treatments: Keytruda — used in cancer immunotherapy — and Gardasil, a vaccine targeting HPV. The analyst added that these two treatments and other underappreciated catalysts have all contributed to Merck's above-peer growth profile. The upgrade comes after the Food and Drug Administration approved the use of Keytruda for treatment with "platinum-containing chemotherapy as neoadjuvant treatment " on Monday.

Persons: Trung Huynh, Huynh, —, Michael Bloom Organizations: Merck, UBS, Food and Drug Administration Locations: China

Hanoi, Vietnam CNN —President Joe Biden will arrive at Chinese leader Xi Jinping’s doorstep on Sunday with a deal in hand to draw yet another one of China’s neighbors closer to the United States. “It’s not going to be easy for Vietnam, because they’re under enormous pressure from China,” the official went on. In Vietnam, it’s not only China whose influence Biden is competing with. On Monday, Biden plans to announce steps to help Vietnam diversify away from an over-reliance on Russian arms, a senior administration official said. “I think that’s a deliberate design by the Biden administration,” said Yun Sun, the China program director at the Stimson Center.

Persons: Joe Biden, Xi Jinping’s, Biden, ”, It’s, playbook, Xi Jinping, Evelyn Hockstein, ” Biden, Modi, Xi, States ’, it’s, ratchets, aggressions, Didier Marti, “ We’re, “, Biden’s, Mao Ning, Vietnam’s, Antony J, Blinken, Trung, Patricia Kim, Le Hoai, Jake Sullivan, Sullivan, ” –, General Secreatary Nguyen, Trong, Yun Sun, ’ Organizations: Vietnam CNN, White House, Korean, Getty, Saturday, Communist Party, Xinhua, China’s, Monday, Communist Party of Vietnam's, Department of State . US Department of State, Biden, Brookings Institution, Communist, NATO, Wing, Stimson Locations: Hanoi, Vietnam, United States, Philippines, China, Beijing, New Delhi, AFP, Asia, States, Russia, Moscow, India, Brazil, South Africa, –, That’s, South China, Washington, South Korea, Helsinki, Japan, Korea, Australia, United Kingdom

Other countries that Vietnam has extended this designation to include China and Russia. Giving the U.S. the same status suggests that Vietnam wants to hedge its friendships as U.S. and European companies are looking for alternatives to Chinese factories. “We find ourselves in a situation where all of these changes around the world are taking place,” Biden explained about the Vietnam trip last month. "We have an opportunity, if we’re smart, to change the dynamic.”Political Cartoons View All 1148 ImagesU.S. trade with Vietnam has already accelerated since 2019. “I’ve gotten a call from the head of Vietnam, desperately wants to meet me when I go to the G20,” Biden said.

Persons: Joe Biden, Biden, they’re, Xi, ” Biden, Gina Raimondo, Raimondo, ” Raimondo, IPEF, Jake Sullivan, Lê Hoài Trung, Trung, Sullivan, Nguyễn Phú Trọng, I’ve, “, Gregory Poling, ” Poling, Poling, ” Organizations: DELHI, United, U.S, Group, Census, Peterson Institute of International Economics, White House, Biden, Communist Party of Vietnam, Southeast Asia Program, Asia Maritime, Center for Strategic, International Studies Locations: Vietnam, United States, China, Asia, Russia, Salt Lake City, India, Cambodia, Malaysia, Indonesia, U.S, Washington, Helsinki, Maine, Beijing, “

☆ Take a look at this skinny 'tube house' that's just 13 feet wide and is home to 3 generations
▼ + stars: | 2023-09-02 | by ( Jyoti Mann | ) www.businessinsider.com time to read: +1 min

An architecture firm has put a modern twist on the popular Vietnamese "tube house." The five-level residence in Ho Chi Minh City, Vietnam is home to three generations. Pham Trung, the studio's director, told Insider that tube houses are also popular in Vietnam because they can provide more housing for people in its crowded cities. The company designed and constructed the skinny house for a family of six for 554 million Vietnamese dong ($230,000). It took the studio about two months to devise a full concept and complete drawings, and a further five months to construct.

Persons: Pham Trung Organizations: Service Locations: Ho Chi Minh City, Vietnam, Wall, Silicon

☆ Here are Credit Suisse's top picks for August, including healthcare and tech stocks
▼ + stars: | 2023-08-06 | by ( Pia Singh | ) www.cnbc.com time to read: +3 min

Credit Suisse refreshed its "top of the crop" stock picks for August, betting on some big-name stocks as investors continue to feed the markets with optimism. Credit Suisse recently highlighted several stocks the bank's analysts think can outperform this month. "It is increasingly clear that greater service levels in the form of faster delivery is leading to consumers assigning a higher value to Prime" memberships, Credit Suisse said. Credit Suisse also named electronics manufacturer Flex Ltd. as a top pick. Credit Suisse assigned a $126 price target on Merck, which implies 20% appreciation from Friday's closing price.

Persons: Stocks, Stephen Ju, Amazon's, Ju, Shannon Cross, Flex, Cross, Trung Huynh, Merck, — CNBC's Michael Bloom Organizations: Suisse, Credit Suisse, Amazon, Flex, Merck, Prometheus Biosciences

☆ Scientists decode an ancient curry recipe
▼ + stars: | 2023-07-25 | by ( Katie Hunt | ) edition.cnn.com time to read: +4 min

The sandstone slab, buried 2 meters (6.5 feet) below the surface, was dug up in 2018 at the Oc Eo archaeological complex in southern Vietnam. The site was once an overseas trading hub of an ancient Southeast Asian kingdom known as Funan, according to a new study of the substances found on the slab. The findings offer clues to how curry — and the people who made it — migrated to Southeast Asia. “Nowadays, preparing curry in Vietnam has become much simpler for most families due to the widespread availability of curry powder in supermarkets. Nguyen added that the team planned to recreate the 2,000-year-old curry based on the ingredients found at the site.

Persons: ”, . Hsiao, chun Hung, ” Hung, Hung, Khanh Trung Kien, Khanh Trung Kien Nguyen, Nguyen Organizations: CNN, Australian National University, Center for Archaeology, Southern Institute of Social Sciences, Oc Eo, Eo Locations: Vietnam, Canberra, India, Southeast Asia, Ho Chi Minh City, South, Cambodia, South Asia

☆ The options for weight loss treatment are about to explode. These are the companies investors need to know
▼ + stars: | 2023-07-03 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +14 min

Wegovy was approved as an obesity treatment in June 2021 , but Ozempic, a Type 2 diabetes treatment, has been used off-label for weight loss. Mounjaro uses GLP-1 and gastric inhibitory polypeptide, or GIP, to help patients lose weight. Eli Lilly's oral drug, orforglipron, has an even better profile . They also could be helpful in assisting patients in maintaining weight loss after they've used the injectable versions, he said. Some have highlighted that oral drugs also may be more manageable for patients who can't handle the idea of giving themselves a once-a-week injection.

Persons: Eli Lilly, we're, Jonathan Wolleben, Wegovy, Lilly's tirzepatide, It's, Mounjaro, Wolleben, Eli Lilly's tirzepatide, Lilly, —, Novo, Eli, it's, they've, FactSet, Altimmune's pemvidutide, Morgan Stanley, Mark Purcell, Purcell, Graig Suvannavejh, Suvannavejh, Roth, Dylan Dupuis, Dupuis, Trung Huynh, Goldman Sachs, Chris Shibutani, Shibutani Organizations: Novo Nordisk, JMP Securities, Citizens Company, Nordisk's Ozempic, Food and Drug Administration, Nordisk, Novo, Zealand Pharma, Shandong Suncadia, GSBR, Biosciences, Fujian Shengdi Pharmaceutical, Mizuho Securities, Terns Pharmaceuticals, American Diabetes Association, Viking Therapeutics, Pfizer, Credit Suisse, AstraZeneca, Therapeutics, Medicare, Medicaid, CNBC Pro's Locations: Danish, Shandong, Fujian, Viking

☆ Credit Suisse downgrades Pfizer, says pharma giant will struggle to keep up with competitors
▼ + stars: | 2023-06-29 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Pfizer 's underperformance could be here to stay, Credit Suisse warned. Analyst Trung Huynh downgraded the pharmaceutical stock to neutral from outperform and cut his price target by $7 to $40. Pfizer said it still has other plans for focusing on obesity, which has been a closely followed area in the pharmaceutical development world. Pfizer has been his worst performing call since the outperform rating at the end of November, with shares underperforming major pharmaceutical peers in the U.S. by 26%. He said concerns that have weighed on the stock include over-optimism on Covid vaccination and booster rates, "ambiguous" guidance on the drug pipeline and negative events for projects in the drug pipeline.

Persons: Trung Huynh, Huynh, CNBC's Michael Bloom Organizations: Pfizer, Credit Suisse Locations: U.S, Covid

☆ Credit Suisse sees Eli Lilly headed higher as Mounjaro users espouse weight loss drug on social media
▼ + stars: | 2023-06-15 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +3 min

Credit Suisse analyst Trung Huynh has combed through social media and is impressed by the awareness — and demand — for GLP-1 medications such as Eli Lilly 's Mounjaro. Among those observations are reports of other potential benefits that patients taking Mounjaro, or tirzepatide, are seeing. Others taking the drug reported benefits such as a reduction in addiction behaviors such as smoking, drinking, gambling and shopping, among other things. However, this may be a function of patients who are trying to use Mounjaro off-label for obesity, he said. Credit Suisse has an outperform rating on Lilly shares, with a $490 price target, which implies more than 9% upside from where Lilly shares closed Wednesday.

Persons: Trung Huynh, Eli Lilly, Huynh, Mounjaro, agonism, Lilly hasn't, semaglutide —, Lilly, —, Michael Bloom Organizations: Credit Suisse, Food and Drug Administration, Novo Nordisk

☆ Analysis: Stelara patent deal puts J&J back on path to $57 bln 2025 revenue forecast
▼ + stars: | 2023-06-05 | by ( Patrick Wingrove | ) www.reuters.com time to read: +4 min

Stelara, introduced in 2009, has been J&J’s top-selling drug since 2019, with sales reaching $9.7 billion in 2022. J&J is forecasting $57 billion in pharmaceutical sales by 2025 after reducing its previous view of $60 billion in April, citing currency dynamics that hurt its pharmaceutical business in 2022. That would add around $4.6 billion to average estimates for pharmaceutical sales, as long as no biosimilars enter the market before 2025. Amgen said last month the confidential settlement it signed with J&J will allow it to sell its Stelara biosimilar no later than Jan. 1, 2025. “If no Stelara biosimilars enter in 2024, I think growth should continue at around 4% in 2023 and 2024,” Huynh said.

Persons: Johnson, Amgen, ”, Vamil, Trung Huynh, ” Huynh, Teva, biosimilar, Divan, Alvotech, Patrick Wingrove, Caroline Humer, Bill Berkrot Organizations: Amgen Inc, Analysts, Stelara, Reuters Graphics Reuters, Reuters, New, J, Credit Suisse, Food and Drug Administration, Alvotech’s, Thomson Locations: New Brunswick , New Jersey, Alvotech’s Reykjavik

☆ Obesity is a chronic disease. It's why treating it will be so profitable unless payers push back
▼ + stars: | 2023-04-30 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +9 min

Lilly manufactures tirzepatide, which is sold under the brand name Mounjaro as a type 2 diabetes treatment. It's the chronic nature of obesity that will make these drugs so profitable, analysts have said. Huynh increased his target due to higher expectations for Mounjaro sales this year. Huynh boosted his prediction for the drug's sales this year to $3.7 billion from an prior estimate of $2.7 billion. "$48 billion is a monster number," Holz said, referring to an annual sales estimate that Bank of America has floated for future Mounjaro sales.

☆ J&J rises as $9 bln talc lawsuit settlement eases overhang on unit spinoff
▼ + stars: | 2023-04-05 | by ( ) www.reuters.com time to read: +2 min

[1/2] A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016. Some analysts were positive about the new settlement that is far bigger than the original offer of $2 billion, as they believe it could bring an end to the lawsuit. J.P. Morgan analyst Chris Schott said in a note the settlement amount was in-line with the brokerage's estimate of $8 billion to $10 billion. "We believe today's announcement should help the IPO of 20% of the consumer unit," Credit Suisse analyst Trung Huynh said in a note. "Overall, we believe the proposed settlement has vast support by the plaintiff supermajority and the top 18 law firms representing the claimants," Jennings said.

☆ J&J rises as $8.9 bln talc lawsuit settlement eases overhang on consumer unit spinoff
▼ + stars: | 2023-04-05 | by ( ) www.reuters.com time to read: +2 min

☆ Credit Suisse calls this group the ultimate 'refuge from stormy seas' with a recession ahead
▼ + stars: | 2022-11-18 | by ( John Melloy | ) www.cnbc.com time to read: +2 min

The firm said investors still need to be selective in the space, however, naming two top ideas in Merck and AbbVie . Credit Suisse says U.S. pharma as a group is trading at a price-earning ratio of 16 times to 17 times while defensive sectors utilities and consumer staples have 18-20 P-E ratios, on average. For AbbVie, it sees 11% upside from here, noting it has the "highest dividend yield among peers." "As such, we believe large-cap biopharma should remain a solid outperformer in the coming months, with portfolios requiring diversity in the defensive names. If markets rally on further clarity, we see our higher-growth names, such as Eli Lilly, being insulated from the rotation away from defensives and back into growth names."

☆ Apple CEO Tim Cook got roasted for his lackluster, bored-looking checkered flag waving at Formula One's US Grand Prix
▼ + stars: | 2022-10-24 | by ( Pete Syme | ) www.businessinsider.com time to read: +3 min

Tim Cook got the honor of waving the checkered flag at Formula One's United States Grand Prix Sunday. People across the world of F1 were quick to roast for his apparent lack of enthusiasm however. "Possibly the worst checkered flag-waving in Formula One history," one prominent commentator said. Cook became the latest in a long line of well-known figures to signal the end of an F1 race by waving the checkered flag, joining the likes of David Beckham and Serena Williams. Sky Sports commentator Ted Kravitz also chimed in, calling it "possibly the worst checkered flag-waving in Formula One history."

Search resuls for: "Trung"

20 mentions found